U.S. J.P. Morgan Healthcare Conference Study Tour IPO Prospectus

From January 8 to 11, 2018, the J.P. Morgan Healthcare Conference will be held as scheduled in San Francisco for four days. During this study tour, we will visit the San Francisco Bay Area, which is not only home to Silicon Valley but also one of the most important biopharmaceutical industry hubs in the United States and a “hub” for top-tier biopharmaceutical talent. The region hosts numerous large biopharmaceutical companies and many innovative enterprises. Together with the Southern California region spanning Los Angeles to San Diego, it forms California, the U.S. state that attracts the largest amount of venture capital investment in the biopharmaceutical sector.

Attending the J.P. Morgan Healthcare Conference, a key initiative of this study tour, will also be the highlight of our trip.

Every year in early January, executives from major global pharmaceutical companies, biotechnology firms, investment banks, consulting firms, and law firms gather at the historic Westin St. Francis Hotel in San Francisco to attend the J.P. Morgan Healthcare Conference.

The J.P. Morgan Healthcare Conference, launched in 1983, has been held for 35 years to date. With total attendance exceeding 40,000, it is the most prestigious investment conference in the pharmaceutical industry, attracting thousands of investors and hundreds of pharmaceutical companies from around the world. Participating companies span the entire healthcare sector, ranging from startups to global giants with market capitalizations exceeding $300 billion, including pharmaceutical companies, medical device manufacturers, health service providers, and non-profit organizations.

Conference Dates: January 8, 2018 – January 11, 2018

Conference Location: San Francisco, USA

(1) One distinctive city, experiencing the unique charm of American innovation culture

San Francisco: The “Hub” for Top Biopharmaceutical Talent;

(2) One premier global health industry summit to grasp the new trends in industrial development

The J.P. Morgan Healthcare Conference, a premier event drawing significant attention from global pharmaceutical companies and investment institutions;

(3) Four seminars on trending industry topics, providing in-depth analysis of industrial development and investment trends

Biopharmaceuticals;

Medical Devices;

Biotechnology;

Medical Artificial Intelligence and Big Data;

(4) Visits to Two Leading Institutions: In-Depth Analysis of Their R&D and Innovation Models

Boston Scientific: A Global Leader in Innovative Medical Solutions;

Genomic Health: A World-Leading Provider of Genomic Diagnostic Tests;

(5) Two industry networking dinners for in-depth discussions with elites in the healthcare and medical fields

Networking Dinner – Industry Analysis, Conference Summary, and Project Cooperation Discussions;

This study tour lasted for 8 days.

Day 1 (Sunday) Beijing–San Francisco: Depart for the “hub” of top biomedical talent

Topic: New Trends in the Development of the Healthcare Sector and Predictions on Hot Topics at the 36th J.P. Morgan Healthcare Conference

Day 2 (Monday) San Francisco: Attend the premier global health industry event and participate in biopharmaceutical-themed seminars

Biopharmaceutical Thematic Seminar

Invite guest speakers to analyze and engage in interactive discussions on the R&D of innovative drugs, valuation of innovative drugs at different stages, insights from the U.S. generic drug market for China, and the impact of medical insurance policies.

Day 3 (Tuesday) San Francisco: Attend the premier global health industry event and participate in thematic seminars on medical devices

Medical Device Thematic Seminar

Invite guest speakers to analyze the development pathways of medical device companies, the state of the U.S. medical device market, trends in R&D and regulatory approval, and the impact of health insurance policies, followed by interactive discussions.

Day 4 (Wednesday) San Francisco: Attend the premier global health industry event and participate in biotechnology-themed seminars

Biotechnology Thematic Seminar

Invited guests will analyze the current state of U.S. biotechnology companies, relevant policies and regulations in this field, R&D and approval trends, and the impact of health insurance policies, followed by an interactive discussion.

Day 5 (Thursday) San Francisco: Attend the premier global health industry event and participate in thematic seminars on medical artificial intelligence and big data

Seminar on Medical Artificial Intelligence and Big Data

Invite guests to analyze and engage in interactive discussions on how AI is transforming healthcare, which medical subsectors will achieve commercialization first, and the strategic layouts of world-leading enterprises in medical artificial intelligence.

Day 6 (Friday) San Francisco: Visit world-leading healthcare services and pharmaceutical R&D institutions, with in-depth analysis of industry development and investment trends

(1) Visit Boston Scientific, a leading global provider of innovative medical solutions

(2) Visit Stryker, the world’s largest orthopedic and medical technology company [Alternative]

(3) Visit Genomic Health, a world-leading provider of genomic diagnostic tests

(4) Visit to OncoMed, a “unicorn” enterprise dedicated to novel cancer therapies [Alternative]

Days 7–8 (Sat–Sun) San Francisco – Beijing: Conclude the wonderful itinerary and return to China

Note: The above itinerary is tentative and subject to partial adjustments during implementation.

2017: Chinese Investors Steal the Show

At the 2017 J.P. Morgan Healthcare Conference, CEOs of approximately 500 healthcare companies delivered presentations across nine venues. The exact number of Chinese attendees at the 2017 J.P. Morgan Conference remains undetermined. Some participants claimed that half of the attendees were Chinese, while others estimated the figure to be around 3,000.What is certain is that China has become the second-largest participating country, after the United States.In just four days, the congress became a “showcase” for numerous global healthcare companies to announce their annual strategies and milestones.

Speaker

2016: Growing Chinese Presence

Compared with previous editions, the 2016 conference saw a marked increase in the presence of senior executives from Chinese pharmaceutical companies and Chinese investors. Mandarin accents could be heard throughout the venue.

It was once unimaginable that Chinese participants would flock to the J.P. Morgan Healthcare Conference. This shift is driven by the surge in Chinese venture capital and the rapid development of the biotechnology sector. With abundant capital available, many foreign companies are now seeking Chinese investors, while well-funded Chinese firms are eager to identify mature projects for investment. Consequently, the timing of the J.P. Morgan Healthcare Conference presents an ideal window of opportunity.

Chinese Faces Increasingly Prevalent at J.P. Morgan Conference, Closely Tied to Domestic Biotech DevelopmentReturnees establishing companies or taking positions in Chinese pharmaceutical firms have brought back advanced technologies, elevating technical standards and enabling meaningful dialogue with the international community.

The J.P. Morgan Healthcare Conference has injected new vitality into global pharmaceutical companies, marking a new milestone in humanity’s fight against disease. It will shape the development and investment trends in the global healthcare sector in the coming period.

Conference Fee: RMB 59,800

Including: exhibition tickets, training fees, visitation fees, invitation letter fees, translation fees, teaching material fees, venue fees, etc.

Meals, accommodation (standard twin room; single room requires payment of the applicable price difference), and scheduled transportation expenses during the overseas period

Personal Accident Insurance Premium (Maximum Compensation up to RMB 1 Million)

Eligibility Criteria:

(1) Founder and Co-founder of Innovative Companies;

(2) Head of the medical institution;

(3) Experts from government agencies and research institutions (including government);

(4) Investors;

(5) Senior executives of listed companies;

(6) Head of Medical Industry Media;

Please scan the QR code to register.Mr. Wang